Invesaro

Stocks Comparison

Privia Health vs GeneDx: revenue, profit, margins and growth compared

Privia Health brought in $2.1B of revenue in fiscal 2025, GeneDx $427.5M in fiscal 2025. Revenue changed by +22.3% at Privia Health and +40.0% at GeneDx on the year before, so GeneDx grew faster. Privia Health kept 1.1% of its revenue as net profit, GeneDx -4.9%.

Side by side, latest fiscal year

PRVAWGS
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2.1B$427.5M
Revenue growth+22.3%+40.0%
Net income$22.9M-$21M
Net margin1.1%-4.9%
Free cash flown/a$14.3M
Free cash flow marginn/a3.3%
Earnings per share (diluted)$0.18-$0.73
Cash$479.7M$105M
Debtn/a$54.5M
Price to earnings109.5n/a
Market value$2.5B$2.6B
Dividend yieldn/an/a
Rank by revenue in sector#106 of 523 · Health care#199 of 523 · Health care

Over the years

Revenue
PRVA FY2019: $786.4MPRVA FY2021: $817.1MPRVA FY2021: $966.2MPRVA FY2022: $1.4BPRVA FY2023: $1.7BPRVA FY2024: $1.7BPRVA FY2025: $2.1BWGS FY2019: $196.2MWGS FY2020: $179.3MWGS FY2021: $212.2MWGS FY2022: $234.7MWGS FY2023: $202.6MWGS FY2024: $305.5MWGS FY2025: $427.5MFY19FY20FY21FY22FY23FY24FY25
PRVA $2.1BWGS $427.5M
Net income
PRVA FY2019: $8.2MPRVA FY2021: $31.2MPRVA FY2021: -$188.2MPRVA FY2022: -$8.6MPRVA FY2023: $23.1MPRVA FY2024: $14.4MPRVA FY2025: $22.9MWGS FY2019: -$29.7MWGS FY2020: -$241.3MWGS FY2021: -$245.4MWGS FY2022: -$549MWGS FY2023: -$175.8MWGS FY2024: -$52.3MWGS FY2025: -$21MFY19FY20FY21FY22FY23FY24FY25
PRVA $22.9MWGS -$21M
Net margin
PRVA FY2019: 1.0%PRVA FY2021: 3.8%PRVA FY2021: -19.5%PRVA FY2022: -0.6%PRVA FY2023: 1.4%PRVA FY2024: 0.8%PRVA FY2025: 1.1%WGS FY2019: -15.1%WGS FY2020: -134.6%WGS FY2021: -115.6%WGS FY2022: -233.9%WGS FY2023: -86.8%WGS FY2024: -17.1%WGS FY2025: -4.9%FY19FY20FY21FY22FY23FY24FY25
PRVA 1.1%WGS -4.9%
Revenue growth
PRVA FY2021: +3.9%PRVA FY2021: +18.3%PRVA FY2022: +40.4%PRVA FY2023: +22.2%PRVA FY2024: +4.7%PRVA FY2025: +22.3%WGS FY2020: -8.6%WGS FY2021: +18.3%WGS FY2022: +10.6%WGS FY2023: -13.7%WGS FY2024: +50.8%WGS FY2025: +40.0%FY20FY21FY22FY23FY24FY25
PRVA +22.3%WGS +40.0%
Free cash flow
PRVA FY2019: $18.6MPRVA FY2021: $38.5MPRVA FY2021: $54.5MPRVA FY2022: $47.1MPRVA FY2023: $80.7MWGS FY2019: -$30.7MWGS FY2020: -$117.2MWGS FY2021: -$199.8MWGS FY2022: -$326.3MWGS FY2023: -$185.4MWGS FY2024: -$34MWGS FY2025: $14.3MFY19FY20FY21FY22FY23FY24FY25
PRVA $80.7MWGS $14.3M

Fiscal years as each company reports them; the two may end in different months.

Questions about Privia Health and GeneDx

Which is bigger by revenue, Privia Health or GeneDx?

Privia Health is bigger by revenue: $2.1B in fiscal 2025, against $427.5M for GeneDx in fiscal 2025.

Which keeps more of its revenue as profit, Privia Health or GeneDx?

Privia Health had a net margin of 1.1% in fiscal 2025; GeneDx had -4.9% in fiscal 2025.

Which grew revenue faster, Privia Health or GeneDx?

In their latest fiscal years revenue changed by +22.3% at Privia Health and +40.0% at GeneDx.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies